Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cells

Authors

  • Tao Zhang,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Junping Zhang,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Xiaona You,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Qian Liu,

    1. Department of Biochemistry, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Yumei Du,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Yuen Gao,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Changliang Shan,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Guangyao Kong,

    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    Search for more papers by this author
  • Youliang Wang,

    1. Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing, China
    Search for more papers by this author
  • Xiao Yang,

    1. Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing, China
    Search for more papers by this author
  • Lihong Ye,

    Corresponding author
    1. Department of Biochemistry, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China
    • Lihong Ye, M.D., Ph.D., Department of Biochemistry, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, P.R. China

      Xiaodong Zhang, M.D., Ph.D., Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, China

    Search for more papers by this author
    • fax: +86-22-23501385

  • Xiaodong Zhang

    Corresponding author
    1. Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China
    • Lihong Ye, M.D., Ph.D., Department of Biochemistry, State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin 300071, P.R. China

      Xiaodong Zhang, M.D., Ph.D., Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, China

    Search for more papers by this author
    • fax: +86-22-23501385


  • Potential conflict of interest: Nothing to report.

Abstract

Hepatitis B virus X protein (HBx) plays critical roles in the development of hepatocellular carcinogenesis (HCC). Yes-associated protein (YAP), a downstream effector of the Hippo-signaling pathway, is an important human oncogene. In the present article, we report that YAP is involved in the hepatocarcinogenesis mediated by HBx. We demonstrated that the expression of YAP was dramatically elevated in clinical HCC samples, hepatitis B virus (HBV)-infected hepatoma HepG2.2.15 cell line, and liver cancer tissues of HBx-transgenic mice. Meanwhile, we found that overexpression of HBx resulted in the up-regulation of YAP in stably HBx-transfected HepG2/H7402 hepatoma cell lines, whereas HBx RNA interference reduced YAP expression in a dose-dependent manner in the above-mentioned cell lines, suggesting that HBx up-regulates YAP. Then, we investigated the mechanism underlying the up-regulation of YAP by HBx. Luciferase reporter gene assays revealed that the promoter region of YAP regulated by HBx was located at nt −232/+115 containing cyclic adenosine monophosphate response element-binding protein (CREB) element. Chromatin immunoprecipitation (ChIP) demonstrated that HBx was able to bind to the promoter of YAP, whereas it failed to work when CREB was silenced. Moreover, we confirmed that HBx activated the YAP promoter through CREB by electrophoretic mobility shift assay and luciferase reporter gene assays. Surprisingly, we found that YAP short interfering RNA was able to remarkably block the HBx-enhanced growth of hepatoma cells in vivo and in vitro. Conclusion: YAP is a key driver gene in HBx-induced hepatocarcinogenesis in a CREB-dependent manner. YAP may serve as a novel target in HBV-associated HCC therapy. (HEPATOLOGY 2012;56:2051–2059)

Ancillary